Cannabinoid1 (CB‐1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose
Published in 2019 by the Journal of Neural Transmission.
August 21, 2019 – Opiant CEO Roger Crystal on Stateside i24News discusses the fight on the opioid crisis.
Published in April 2019 by ASPET Journals.
Published in March 2019 by American College of Neuropsychopharmacology.
Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose
Published in 2019 by the Journal of Clinical Pharmacology.
October 10, 2018 – Opiant CEO Dr. Roger Crystal discusses teaming with HHS on new opioid overdose nasal spray.
August 3, 2018 – Opiant CEO Dr. Roger Crystal discusses NARCAN® following singer Demi Lovato’s hospitalization.